Insider Transactions in Q1 2025 at Lemaitre Vascular Inc (LMAT)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 14
2025
|
Trent G Kamke Senior V. P., Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,709
+21.85%
|
$108,360
$40.46 P/Share
|
Mar 13
2025
|
Trent G Kamke Senior V. P., Operations |
SELL
Open market or private sale
|
Direct |
4,520
-52.32%
|
$357,080
$79.92 P/Share
|
Mar 12
2025
|
Trent G Kamke Senior V. P., Operations |
SELL
Open market or private sale
|
Direct |
2,009
-26.53%
|
$164,738
$82.12 P/Share
|
Mar 12
2025
|
Trent G Kamke Senior V. P., Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,009
+20.97%
|
$46,207
$23.56 P/Share
|
Mar 10
2025
|
Dorian Paul Le Blanc Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,221
+50.0%
|
-
|
Mar 07
2025
|
David B Roberts President and Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,818
+13.55%
|
$98,630
$35.48 P/Share
|
Mar 04
2025
|
Lawrence J Jasinski Director |
SELL
Open market or private sale
|
Direct |
3,142
-54.65%
|
$289,064
$92.0 P/Share
|
Feb 28
2025
|
John A Roush Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.03%
|
-
|
Feb 28
2025
|
John A Roush Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+6.54%
|
-
|
Feb 28
2025
|
Martha Shadan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.05%
|
-
|
Feb 28
2025
|
Martha Shadan Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+9.54%
|
-
|
Feb 28
2025
|
Bridget A Ross Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.03%
|
-
|
Feb 28
2025
|
Bridget A Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+6.54%
|
-
|
Feb 28
2025
|
Lawrence J Jasinski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.02%
|
-
|
Feb 28
2025
|
Lawrence J Jasinski Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+3.43%
|
-
|
Feb 28
2025
|
John James O'Connor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.0%
|
-
|
Feb 28
2025
|
John James O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+0.35%
|
-
|
Feb 28
2025
|
Joseph P Pellegrino Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
203
-2.08%
|
$18,473
$91.85 P/Share
|
Feb 28
2025
|
Joseph P Pellegrino Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5
+0.05%
|
-
|
Feb 28
2025
|
Joseph P Pellegrino Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
685
+6.56%
|
-
|
Feb 28
2025
|
Trent G Kamke Senior V. P., Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-1.69%
|
$8,281
$91.85 P/Share
|
Feb 28
2025
|
Trent G Kamke Senior V. P., Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2
+0.04%
|
-
|
Feb 28
2025
|
Trent G Kamke Senior V. P., Operations |
BUY
Grant, award, or other acquisition
|
Direct |
308
+5.41%
|
-
|
Feb 28
2025
|
David B Roberts President and Director |
SELL
Payment of exercise price or tax liability
|
Direct |
203
-1.32%
|
$18,473
$91.85 P/Share
|
Feb 28
2025
|
David B Roberts President and Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5
+0.03%
|
-
|
Feb 28
2025
|
David B Roberts President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
685
+4.27%
|
-
|
Feb 28
2025
|
George W Le Maitre Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-0.02%
|
$40,677
$91.85 P/Share
|
Feb 28
2025
|
George W Le Maitre Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11
+0.0%
|
-
|
Feb 28
2025
|
George W Le Maitre Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,510
+0.08%
|
-
|
Feb 18
2025
|
David B Roberts President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
129
+0.87%
|
-
|